416 related articles for article (PubMed ID: 28249566)
1. Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2017 Mar; 18(1):140. PubMed ID: 28249566
[TBL] [Abstract][Full Text] [Related]
2. DDI-PULearn: a positive-unlabeled learning method for large-scale prediction of drug-drug interactions.
Zheng Y; Peng H; Zhang X; Zhao Z; Gao X; Li J
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):661. PubMed ID: 31870276
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance.
Iga K
J Pharm Sci; 2016 Mar; 105(3):1307-17. PubMed ID: 26886336
[TBL] [Abstract][Full Text] [Related]
4. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.
Cheng F; Zhao Z
J Am Med Inform Assoc; 2014 Oct; 21(e2):e278-86. PubMed ID: 24644270
[TBL] [Abstract][Full Text] [Related]
5. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
[TBL] [Abstract][Full Text] [Related]
6. Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.
Callegari E; Kalgutkar AS; Leung L; Obach RS; Plowchalk DR; Tse S
Drug Metab Dispos; 2013 Dec; 41(12):2047-55. PubMed ID: 23792812
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
8. Extracting drug-enzyme relation from literature as evidence for drug drug interaction.
Zhang Y; Wu HY; Du J; Xu J; Wang J; Tao C; Li L; Xu H
J Biomed Semantics; 2016; 7():11. PubMed ID: 26955465
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome-P450-Mediated Drug
Steyn SJ; Varma MVS
Mol Pharm; 2020 Aug; 17(8):3024-3032. PubMed ID: 32589434
[TBL] [Abstract][Full Text] [Related]
10. Simulations of Cytochrome P450 3A4-Mediated Drug-Drug Interactions by Simple Two-Compartment Model-Assisted Static Method.
Iga K; Kiriyama A
J Pharm Sci; 2017 May; 106(5):1426-1438. PubMed ID: 28089686
[TBL] [Abstract][Full Text] [Related]
11. Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.
Song D; Chen Y; Min Q; Sun Q; Ye K; Zhou C; Yuan S; Sun Z; Liao J
J Clin Pharm Ther; 2019 Apr; 44(2):268-275. PubMed ID: 30565313
[TBL] [Abstract][Full Text] [Related]
12. A novel integrated action crossing method for drug-drug interaction prediction in non-communicable diseases.
Hunta S; Yooyativong T; Aunsri N
Comput Methods Programs Biomed; 2018 Sep; 163():183-193. PubMed ID: 30119852
[TBL] [Abstract][Full Text] [Related]
13. Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.
Min JS; Bae SK
Arch Pharm Res; 2017 Dec; 40(12):1356-1379. PubMed ID: 29079968
[TBL] [Abstract][Full Text] [Related]
14. QSAR Modeling and Prediction of Drug-Drug Interactions.
Zakharov AV; Varlamova EV; Lagunin AA; Dmitriev AV; Muratov EN; Fourches D; Kuz'min VE; Poroikov VV; Tropsha A; Nicklaus MC
Mol Pharm; 2016 Feb; 13(2):545-56. PubMed ID: 26669717
[TBL] [Abstract][Full Text] [Related]
15. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 Enzymes.
Preskorn SH
J Psychiatr Pract; 2020 Mar; 26(2):126-134. PubMed ID: 32134885
[TBL] [Abstract][Full Text] [Related]
16. Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning.
Zhang Y; Qiu Y; Cui Y; Liu S; Zhang W
Methods; 2020 Jul; 179():37-46. PubMed ID: 32497603
[TBL] [Abstract][Full Text] [Related]
17. Disposition pathway-dependent approach for predicting organic anion-transporting polypeptide-mediated drug-drug interactions.
Hu ZY
Clin Pharmacokinet; 2013 Jun; 52(6):433-41. PubMed ID: 23494981
[TBL] [Abstract][Full Text] [Related]
18. Mining and visualizing high-order directional drug interaction effects using the FAERS database.
Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L
BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790
[TBL] [Abstract][Full Text] [Related]
19. SubGE-DDI: A new prediction model for drug-drug interaction established through biomedical texts and drug-pairs knowledge subgraph enhancement.
Shi Y; He M; Chen J; Han F; Cai Y
PLoS Comput Biol; 2024 Apr; 20(4):e1011989. PubMed ID: 38626249
[TBL] [Abstract][Full Text] [Related]
20. Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.
Cheng Z; Zhou S; Wang Y; Liu H; Guan J; Chen YP
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1832-1843. PubMed ID: 28113437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
